Basement membrane and growth factor gene expression in normal and diabetic human retinas

被引:90
作者
Spirin, KS
Saghizadeh, M
Lewin, SL
Zardi, L
Kenney, MC
Ljubimov, AV
机构
[1] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Sch Med, Ophthalmol Res Labs, Los Angeles, CA 90048 USA
[2] Ist Nazl Ric Canc, I-16132 Genoa, Italy
关键词
diabetic retinopathy; basement membrane; tenascin-C; fibronectin; vascular endothelial growth factor; placenta growth factor; gene expression;
D O I
10.1076/ceyr.18.6.490.5267
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose. Recently(1), we found abnormal accumulation of several extracellular matrix components in retinal basement membranes in human diabetic retinopathy (DR). Others have described increased levels of various growth factors within the vitreous of DR patients. This study examined mRNA levels of these extracellular matrix components and growth factors within human retinal tissues. Methods. Total retinal RNA was analyzed by semiquantitative reverse transcription-polymerase chain reaction (RT-PCR). RT-PCR products were identified by Southern blotting. Samples were normalized with respect to beta(2)-microglobulin cDNA. Twenty-one retinas were analyzed: 6 normal, 7 diabetic without DR and 8 diabetic with DR. Results. In diabetic retinas without DR, the expression levels of most genes were similar to normal. In DR retinas, tenascin-C mRNA expression increased compared to both normal and diabetics without DR. By RT-PCR and Northern blotting, mainly small tenascin-C mRNA isoforms were expressed, and some of them were elevated in DR retinas. Fibronectin mRNA was elevated in DR compared to normal retinas, possibly due to the overexpression of extradomain A-containing isoform (ED-A+, or cellular fibronectin). In DR retinas, gene expression of vascular endothelial growth factor and placenta growth factor was elevated compared to normal, although mRNA for these growth factors receptors (VEGFR-1/Flt-1 and VEGFR-2/KDR) did not change significantly. Transforming growth factor-pr mRNA also increased in DR retinas. Conclusions. The data suggest that proliferative DR development may be associated with increased retinal expression of vascular endothelial growth factor, placenta growth factor and transforming growth factor-beta 1 that possibly triggers the deposition of small tenascin-C isoforms in the blood vessel walls, angiogenesis-stimulating tenascin-C may further promote diabetic retinal neovascularization.
引用
收藏
页码:490 / 499
页数:10
相关论文
共 57 条
[1]   PRODUCTION AND CHARACTERIZATION OF MONOCLONAL-ANTIBODIES SPECIFIC FOR DIFFERENT EPITOPES OF HUMAN TENASCIN [J].
BALZA, E ;
SIRI, A ;
PONASSI, M ;
CAOCCI, F ;
LINNALA, A ;
VIRTANEN, I ;
ZARDI, L .
FEBS LETTERS, 1993, 332 (1-2) :39-43
[2]  
Behzadian MA, 1998, GLIA, V24, P216, DOI 10.1002/(SICI)1098-1136(199810)24:2<216::AID-GLIA6>3.3.CO
[3]  
2-D
[4]   Intravitreal growth factors in proliferative diabetic retinopathy: Correlation with neovascular activity and glycaemic management [J].
Boulton, M ;
Gregor, Z ;
McLeod, D ;
Charteris, D ;
JarvisEvans, J ;
Moriarty, P ;
Khaliq, A ;
Foreman, D ;
Allamby, D ;
Bardsley, B .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1997, 81 (03) :228-233
[5]   VEGF localisation in diabetic retinopathy [J].
Boulton, M ;
Foreman, D ;
Williams, G ;
McLeod, D .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1998, 82 (05) :561-568
[6]  
BOURDON MA, 1983, CANCER RES, V43, P2796
[7]  
CANFIELD AE, 1995, J CELL SCI, V108, P797
[8]   THE FIBRONECTIN ISOFORM CONTAINING THE ED-B ONCOFETAL DOMAIN - A MARKER OF ANGIOGENESIS [J].
CASTELLANI, P ;
VIALE, G ;
DORCARATTO, A ;
NICOLO, G ;
KACZMAREK, J ;
QUERZE, G ;
ZARDI, L .
INTERNATIONAL JOURNAL OF CANCER, 1994, 59 (05) :612-618
[9]   Adhesion mediated by fibronectin's alternatively spliced ED(b) (EIIIB) and its neighboring type III repeats [J].
Chen, WS ;
Culp, LA .
EXPERIMENTAL CELL RESEARCH, 1996, 223 (01) :9-19
[10]   TENASCIN VARIANTS - DIFFERENTIAL BINDING TO FIBRONECTIN AND DISTINCT DISTRIBUTION IN CELL-CULTURES AND TISSUES [J].
CHIQUETEHRISMANN, R ;
MATSUOKA, Y ;
HOFER, U ;
SPRING, J ;
BERNASCONI, C ;
CHIQUET, M .
CELL REGULATION, 1991, 2 (11) :927-938